http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-353768-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b6fc801b5bfe5304ffa40d938db6e09
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-08
filingDate 1968-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1969-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-353768-A1
titleOfInvention PROCEDURE FOR THE PREPARATION OF NEW 1-SUBSTITUTED 3-ARILSULFONI- LUREAS.
abstract Novel compounds I (including salts with bases) wherein R signifies H, F, Cl, Br, NH 2 , alkyl, alkoxy, alkylthio, or alkanoyl, are obtained by reacting an appropriate sulphonyl-isocyanate or -isothiocyanate, or a reactive functional derivative of an appropriate sulphonyl-carbamic acid or -thiocarbamic acid (each foregoing reactant being substituted by the group R or by a group which can be converted into the amino group by hydrolysis or reduction) with 1-amino-2-oxaadamantane (obtained by the hydrogenation of 1 - benzylamino - 2 - oxa - adamantane hydrochloride which, in turn, is obtained by treating 3 - benzylamino - 2 - oxa - adamantan - 1 - ol with lithium aluminium hydride this aminoalcohol is prepared by the interaction of bicyclo- [3,3,1]-nonan-3,7-dione and benzylamine 1- amino-2-oxa-adamantane hydrochloride is also described) or with an alkali metal derivative thereof where necessary resulting thioureas are converted into the corresponding ureas. 1 - (p - Tolylsulphonyl) - 3 - (2 - oxa - adamant- 1-yl)-thiourea is prepared by the interaction of p-tolylsulphonyl isothiocyanate and 1-amino-2- oxa-adamantane. Pharmaceutical preparations having hypoglycemic action contain as active ingredient compounds I administration is orally or parenterally.
priorityDate 1967-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451782097
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449445756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77898
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414671774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421329868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426047928
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160227817
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415764006
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154193121
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18452504
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431935123
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154097038
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432156198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19708696
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4738534
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483880

Total number of triples: 27.